The global ocular pain oral treatment market size was valued at USD 35.21 Million in 2024 and is expected to reach USD 62.33 Million by 2032, at a CAGR of 7.40% during the forecast period
The market growth is largely fueled by increasing prevalence of ocular pain conditions, rising awareness of eye health, and advancements in oral treatment formulations, leading to higher adoption of effective therapies in both clinical and retail settings
Furthermore, growing consumer demand for convenient, safe, and fast-acting oral treatments for ocular pain is driving market expansion. These factors are accelerating the uptake of novel therapeutic solutions, thereby significantly boosting the industry’s growth
3 Views